RecruitingISRCTN23197625
This study is looking at whether 1 can help people with Persecutory delusions in the context of schizophrenia or related diagnosis, Mental and Behavioural Disorders, or Schizophrenia or related diagnosis. Participants take part in 1 and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- The Efficacy and Mechanism Evaluation Programme (MRC/NIHR) (UK)
- Condition
- Schizophrenia
RecruitingISRCTN71305621
This study is looking at whether Medication decisions will be made by the participant's own clinician can help people with Schizophrenia, schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Institute of Psychiatry, Kings College London (UK)
- Condition
- Schizophrenia
RecruitingISRCTN60687844
This study is looking at whether The study is a randomised control trial can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- King's College London (KCL) (UK)
- Condition
- Schizophrenia
RecruitingISRCTN71943786
This study is looking at care and outcomes for people with psychosis. Taking part may give some people access to 1, but direct benefit is not guaranteed.
SchizophreniaOtherFrom 18 Years to 35 Years
- Countries
- United Kingdom
- Sponsor
- Kings College London (KCL) (UK)
- Condition
- Schizophrenia
RecruitingISRCTN70185866
This study is looking at care and outcomes for people with psychosis. Direct benefit is not guaranteed, but the study may help researchers improve future care.
SchizophreniaOther
- Countries
- United Kingdom
- Sponsor
- Cambridgeshire and Peterborough NHS Foundation Trust (UK)
- Condition
- Schizophrenia
RecruitingISRCTN59501939
This study is looking at whether 1 can help people with psychosis. Participants take part in 1 and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Kings College London (KCL) (UK)
- Condition
- Schizophrenia
RecruitingISRCTN68824876
This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- Imperial College London (UK)
- Condition
- Schizophrenia
RecruitingISRCTN95603741
This study is looking at a support or therapy approach for people with psychosis. Participants take part in the program or support approach and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Hampshire Partnership NHS Foundation Trust (UK)
- Condition
- Schizophrenia
RecruitingISRCTN42305247
This study is testing a medication approach for people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Imperial College London (UK)
- Condition
- Schizophrenia
RecruitingISRCTN37110238
This study is looking at whether a digital support tool can help people with psychosis. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Hertfordshire Partnership Foundation NHS Trust (UK)
- Condition
- Schizophrenia
RecruitingISRCTN55488371
This study is looking at whether a digital support tool can help people with psychosis. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOther
- Countries
- United Kingdom
- Sponsor
- South London and Maudsley NHS Trust (UK)
- Condition
- Schizophrenia
RecruitingISRCTN67096137
This study is looking at whether cognitive behavioural therapy can help people with psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University of Reading (UK)
- Condition
- Schizophrenia
RecruitingISRCTN25898179
This study is looking at whether Intervention arm: Services will receive the GetREAL intervention as developed in Phase 2 can help people with psychosis. Participants take part in Intervention arm: Services will receive the GetREAL intervention as developed in Phase 2 and complete follow-up assessments.
SchizophreniaOther
- Countries
- United Kingdom
- Sponsor
- University College London (UK)
- Condition
- Schizophrenia
RecruitingISRCTN42412532
This study is looking at whether TOCTAP is a randomised, three-armed double-blind study with 60 patients suffering from schizophrenia, using DSM-IV diagnostic criteria can help people with Schizophrenia, cognitive functions, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Germany
- Sponsor
- RWTH Aachen University (Germany)
- Condition
- Schizophrenia
RecruitingISRCTN84216587
This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Queen Mary University of London and Barts and the London NHS Trust (UK)
- Condition
- Schizophrenia
RecruitingISRCTN32434568
This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom, Finland, Italy
- Sponsor
- University of Oxford (UK)
- Condition
- Schizophrenia
RecruitingISRCTN93019988
This study is looking at whether a digital support tool can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Germany
- Sponsor
- Klinikum Fulda gAG (Germany)
- Condition
- Schizophrenia
RecruitingISRCTN94846422
This study is looking at whether a digital support tool can help people with Schizophrenia/schizoaffective disorder, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in a digital support tool and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Queen Mary University of London (UK)
- Condition
- Schizophrenia
RecruitingISRCTN74919979
This study is looking at a support or therapy approach for people with Schizophrenia, schizotypal disorders or delusional disorders, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Finland
- Sponsor
- Academy of Finland (Finland)
- Condition
- Schizophrenia
RecruitingISRCTN54975957
This study is looking at whether Mirtazapine was added to the on-going pharmacotherapy with risperidone in the mirtazapine group can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOther
- Countries
- South Korea
- Sponsor
- Bundang CHA Hospital (South Korea)
- Condition
- Schizophrenia
RecruitingISRCTN61794329
This observational study is following people with Early phase psychosis, Mental and Behavioural Disorders, or Schizophrenia to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
SchizophreniaOther
- Countries
- Switzerland, United States
- Sponsor
- Swiss National Science Foundation (Fonds National Suisse de la Recherche Scientifique [SNSF]) (Switzerland)
- Condition
- Schizophrenia
RecruitingISRCTN56877013
This study is looking at whether a digital support tool can help people with Mental health/schizophrenia, Mental and Behavioural Disorders, or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom, India
- Sponsor
- Kings College London (UK)
- Condition
- Schizophrenia
RecruitingISRCTN50247539
This study is looking at whether Current information as of 10/12/09: Patients will have 12 one-hour group therapy sessions with a psychologist can help people with Psychic disorders, schizophrenia and other psychosis, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in Current information as of 10/12/09: Patients will have 12 one-hour group therapy sessions with a psychologist and complete follow-up assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Netherlands
- Sponsor
- University Medical Center Groningen (UMCG) (Netherlands)
- Condition
- Schizophrenia
RecruitingISRCTN64695913
This study is looking at whether There is a 14-day screening period and a 3 to 7-day placebo washout period before randomisation of the participants for the trial can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherOver 18 Years
- Countries
- Colombia, Germany, India, Philippines, Romania, Russian Federation, Ukraine, United States
- Sponsor
- Dainippon Sumitomo Pharma America Inc. (USA)
- Condition
- Schizophrenia
RecruitingISRCTN44297014
This study is testing a medication approach for people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- Colombia, Germany, India, Philippines, Romania, Russian Federation, Ukraine, United States
- Sponsor
- Dainippon Sumitomo Pharma America Inc. (USA)
- Condition
- Schizophrenia